BioIntelliSense announced today that it received FDA clearance for its rechargeable BioButton multi-patient wearable and BioDashboard system. The BioButton device expands the company’s portfolio of continuous patient monitoring solutions with a rechargeable, reusable inpatient solution. It automates vital sign collection across medical surgical units, specialty care areas and emergency departments. The company says it delivers […]
BioIntelliSense
iRhythm enters licensing deal for BioIntelliSense sensor tech
iRhythm Technologies announced today that it signed an exclusive license agreement with BioIntelliSense to develop and commercialize cardiac monitoring technology. The deal centers around certain patented technology assets within ambulatory cardiac monitoring (ACM). iRhythm aims to utilize BioIntelliSense’s multiparameter sensing technologies to expand the capabilities of its own platform. “We believe that the licensed technology […]
BioIntellisense acquires AlertWatch to expand patient monitoring portfolio
BioIntelliSense announced today that it acquired AlertWatch, an FDA-cleared patient monitoring platform. AlertWatch offers integration, data analysis and a patented display of contextual patient data to help in clinical decision-making. BioIntelliSense in August partnered with Medtronic on the distribution of patient monitoring technology. Through this partnership, it intends to distribute AlertWatch to hospitals throughout the […]
Medtronic, BioIntelliSense partner on distribution of wearable patient monitoring device
Medtronic (NYSE:MDT) announced today that it partnered with BioIntelliSense on distribution rights for the BioButton device. BioButton, a multi-paremter wearable for continuous, connected monitoring, measures up to 1,440 vital sign measurements per day. Its measurements include skin temperature, respiratory rate at rest, and heart rate at rest. The device, combined with advanced analytics, helps clinicians […]
Philips wins $2.8M from DoD for early COVID-19 detection tech
The U.S Defense Department has selected Royal Philips (NYSE:PHG) and BioIntelliSense to receive nearly $2.8 million. Amsterdam-based Philips (which has its U.S. base in Cambridge, Mass.) was selected by the DoD through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms, according to a news […]
Philips launches new face scanning tech, partners with BioIntelliSense on telehealth
Royal Philips (NYSE:PHG) today announced two separate steps toward helping patients receive remote care as telehealth’s importance continues to grow. Amsterdam-based Philips said today that it launched its Philips Respironics mask selector 3D facial scanning system for fitting masks and formed a strategic collaboration with BioIntelliSense to monitor at-risk patients from the hospital into the home. […]
BioIntelliSense wins FDA nod for BioSticker continuous vital sign monitor
BioIntelliSense announced that it won FDA 510(k) clearance for its BioSticker on-body sensor for scalable remote care and initiated the U.S. commercial launch of the product last week. The BioSticker is designed to allow for continuous monitoring of vital signs and actionable insights to provide opportunities for early detection of potentially avoidable complications from a […]
